Objective: We sought to determine the prevalence of and factors associated with self-medication in patients with rheumatic diseases. Material and Methods: An analytical cross-sectional study was conducted from February to July 2013 in the rheumatology department.
Introduction
The World Health Organization (WHO) defines self-medication as practices by which people deal with aches and health conditions with drugs that are approved and available without prescription and are safe and effective when used according to inscriptions (1) . In addition, self-medication is called anarchic when treating a real or imagined pathological situation by drugs selected without medical advice or without consulting a health care professional in his area of competences (1) . Rheumatic disease is a source of pain and disability that promotes responsible or anarchic self-medication. In France, 80% of the population uses self-medication and 20% of the population suffers from rheumatic diseases (2) . In sub-Saharan Africa, the existing data mainly concern the overall self-medication rate, which varies from 11.9% to 75.7% (3, 4) . Self-medication appears to be more common in women and is associated with a low socioeconomic level. To the best of our knowledge, no study has investigated self-medication in rheumatology in sub-Saharan Africa countries. The purpose of this study was to describe the prevalence of and factors associated with self-medication in rheumatology in a sub-Saharan African country.
Material and Methods
An analytical cross-sectional study was conducted from February to July 2013 in the rheumatology department. All patients aged over 15 years who presented during the study period for rheumatologic diseases and who gave their consent were included in the study. We did not include patients who forgot the medications taken. All patients were asked about their practice of self-medication. Data were collected using a questionnaire that included questions related to socio-demographic characteristics (age, sex, occupation), diagnosis, performance of patients on self-medication (definition, period, rhythm, and motivation), and role of health professionals according to self-medication (guide, application of pharmaceutical advice). The level of pain was assessed using a visual analogue scale. All patients underwent complete clinical examination by a rheumatologist and further investigations if necessary.
Statistical analysis
The data were entered using Epi Data software version 3.1 and analyzed with SPSS Version 21. The significance level of 0.05 was used. 
Results

Patients characteristics
In total, 203 patients were included in the study during the study period. They were 156 women and 47 men, with a sex ratio of 0.32. Of these 203 patients, 146 (71.92%) had practiced self-medication in general, whereas 99 (48.80%) patients had used self-medication for a rheumatic disease. The mean age of these patients was 45.5±13.5 years (range: 18-75 years). The age group of 45-55 years was more represented. The distribution of patients by age group is shown in Figure 1 . State officials (44 patients) accounted for 44.4% of patients, whereas housewives and traders accounted for 16.2% and 8.1% of patients, respectively.
Eighty-one patients were schooled. Of these, 20.2%, 50.5%, and 11.1% had education up to the high school level, secondary school level, and primary school level (p<0.05), respectively. Comorbidities were represented by peptic ulcer in 7 patients (7.1%), kidney diseases in 5 patients (5.1%), and liver disease in 3 patients (3%). Reported diagnoses were dominated by low back pain (29.29%) and osteoarthritis of knee (12.12%). Table 1 shows the distribution of patients according to the final diagnosis. On the visual analog scale, the level of pain was >70 in 57.6% of patients, between 40 and 70 in 30.3% of patients, and <40 in 12.1% of patients.
Characteristics of self-medication Definition Fifty-six patients (56.6%) defined self-medication as the act of self-care without going to the doctor. Table 2 shows the distribution of patients according to their definition of self-medication.
Period Seventy-nine patients (79.8%) engaged in self-medication before rheumatology consultation. Two patients practiced self-medication after consultation and 18 (18.2%) practiced self-medication before and after consultation (p<0.05).
Frequency, source, motivation, and channel of self-medication Fifty-five patients (55.5%) had often practiced self-medication, 28 (28.3%) had rarely practiced self-medication, and 16 (16.2%) had practiced casual self-medication. Drugs were bought from the pharmacy in 89% of cases and from the black market in 11% of cases. Thirty-nine patients (39.4%) said that they had used extra traditional medicines. Fifty-two patients Figure 1 . Distribution of patients number according age (years) groups (52.5%) were motivated by symptoms already known. Word of mouth (45.5%) was the most widely used channel. Table 3 lists the motivations and channels of self-medication. Drugs taken in self-medication were dominated by anti-inflammatory drugs. Table 4 shows the distribution of patients by the type of drugs. Ten patients (10.1%) were unaware of the risk associated with self-medication. Sixty-seven (67.7%) patients never asked for advice in pharmacies. Figure 2 illustrates the application of pharmaceutical advice through self-medication in rheumatology.
Risk factors
In multivariate analysis, sex, education level, and occupation of the patients were statistically associated with self-medication. Table 5 shows the distribution of patients according to the factors associated with self-medication.
Discussion
The frequency of self-medication in general was 71.92%; it was higher than that for a specific rheumatologic symptom (48.80%). The frequency of self-medication for a rheumatic disease has been little studied; it was 65% in the studies conducted in France and Spain (2, 5) . The frequency of self-medication in general ranges from 11.9% to 75.7% depending on the country (3, 4, 6-10). The mean age of patients who practiced self-medication for rheumatic diseases was 45.5 years, which is lower than that reported by a study conducted in France (65 years) (2). This mean age was similar to that of patients generally observed in the rheumatology department (11) . Three factors appear to be statistically associated with self-medication for rheumatic diseases (gender, education level, and occupation) in our study. Female predominance has been reported in several studies (5). Although our sample was dominated by women (76.8%), self-medication for rheumatic diseases was significantly practiced by men (66%); this could be explained by the fact that men are better educated in our country. Furthermore, 60% of patients in our study with high school-level education had practiced self-medication; a study in the elderly in urban areas in Mexico reported that self-medication was statistically associated with illiteracy or low education level (8) . This association is questionable because 92.50% of patients practicing self-medication in general in Congo were educated, with 12.92% having university-level education (4). Self-medication appears to be a complex phenomenon probably integrating socio-cultural habits of patients with a tendency to self-support for health problems they believe to be minor.
As most rheumatologic diseases are dominated by pain, the most commonly used drugs are anti-inflammatory (5, 12) ; however, the side effects and risks of this therapeutic class appear to be little or poorly understood by many rheumatologic patients (13) . These risks are related to the lack of possible control of dosages, duration of treatment, drug interactions, allergic or iatrogenic effects, and comorbidities. The frequency of self-medication appears to decrease after consultation. It can be useful to temporarily alleviate a major disorder with short-term medication; on the contrary, it becomes dangerous if it takes long to see a doctor (14) . Self-medication should be regulated by patient education, including relevant infor- Our study has limitations. We conducted this study in an urban setting and therefore the conclusions drawn here may not be applicable to rural areas. We relied on self-reported data collected using a questionnaire through an interview, which may underestimate the prevalence of self-medication.
Self-medication for rheumatologic symptoms appears to be less common than self-medication in general. Its definition is unclear and patients are guided by word of mouth. Self-medication appears to be associated with male gender and high level of education. The procedures for responsible self-medication should be defined in Africa in order to minimize the risks.
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